GlassScriptPhysician profile
Joanne Turner
NPI 1225140973
$3,923.48
in general payments reported to CMS, 2019-2025
18 companies · $686 in 2025
The $686 reported for 2025 was more than what 78% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $457 · 2022: $733 · 2023: $1,161 · 2024: $886 · 2025: $686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,288 · Education: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,288.00 |
| Education | $444.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $1,577.18 | 2021-2025 | |
| Axsome Therapeutics, INC. | $677.14 | 2022-2025 | Sunosi |
| Harmony Biosciences LLC | $495.52 | 2021-2025 | Wakix |
| Avadel Cns Pharmaceuticals, LLC | $239.45 | 2023-2025 | Lumryz |
| Fisher & Paykel Healthcare INC | $169.57 | 2021-2024 | Fisher & Paykel Healthcare |
| Arbor Pharmaceuticals, INC. | $164.63 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $147.47 | 2023-2025 | Horizant, Horizant |
| Inspire Medical Systems, INC. | $95.02 | 2024-2025 | Inspire |
| Abbott Laboratories | $77.48 | 2021-2022 | |
| Eisai INC. | $55.95 | 2021 | |
| Idorsia Pharmaceuticals US INC | $54.78 | 2023-2025 | Quviviq, Quviviq |
| Genzyme Corporation | $36.34 | 2023 | |
| Merck Sharp & Dohme LLC | $31.72 | 2023 | Belsomra |
| Vanda Pharmaceuticals INC. | $26.24 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $24.87 | 2023 | Dupixent |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $19.70 | 2021 | |
| Resmed Corp | $15.54 | 2022 | |
| Corium, LLC | $14.88 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanne Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.